ArticleTherapeutic advances in neurological disorders2021

Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis.

Gisela Zanga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.